CMN Weekly (9 July 2021)

Some of the best links we picked up around the internet

By: Gorm Palmgren - Jul. 9, 2021

Top picks

Industry

Research

COVID-19

  • A new CRISPR-based diagnostic tool for point-of-care COVID-19 detection with the naked eye is described by Chinese researchers. The method uses gold nanoparticles and CRISPR/Cas12a-assisted RT-LAMP and can detect four copies/μL of SARS-CoV-2 RNA in less than 40 minutes.

Reviews

Opinion

Videos and Podcasts

Tags

HashtagArticleHashtagMissing linksHashtagNewsHashtagCMN Weekly

CLINICAL TRIALS
Acute Myeloid Leukemia, AML, (NCT05066165)
Sponsors:
Intellia Therapeutics
IndicatorIndicator
IND Enabling
Phase I
Phase II
Phase III
Indicator
IND Enabling
Phase I
Phase II
Phase III
CAR T for CD19+ hematological cancers, (NCT05037669)
Sponsors:
University of Pennsylvania
Indicator
IND Enabling
Phase I
Phase II
Phase III
View all clinical trials
close
Search CRISPR Medicine